Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 666.879 million compared to CNY 373.926 million a year ago. Operating income was CNY 234.278 million compared to CNY 49.838 million a year ago. Net income was CNY 200.406 million compared to CNY 44.653 million a year ago. Basic earnings per share from continuing operations was CNY 1.19 compared to CNY 0.28 a year ago. Diluted earnings per share from continuing operations was CNY 1.13 compared to CNY 0.28 a year ago.